Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Non-cash Items (2018 - 2025)

Dna X's Non-cash Items history spans 8 years, with the latest figure at $499000.0 for Q4 2025.

  • Quarterly results put Non-cash Items at $499000.0 for Q4 2025, up 49.6% from a year ago — trailing twelve months through Dec 2025 was $499000.0 (up 49.6% YoY), and the annual figure for FY2025 was $499000.0, up 49.6%.
  • Non-cash Items for Q4 2025 was $499000.0 at Dna X, down from $692000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $3.3 million in Q1 2023 to a low of $9000.0 in Q3 2021.
  • The 5-year median for Non-cash Items is $441674.0 (2025), against an average of $764561.9.
  • The sharpest move saw Non-cash Items crashed 91.72% in 2022, then surged 5105.44% in 2023.
  • Year by year, Non-cash Items stood at $9000.0 in 2021, then soared by 3877.78% to $358000.0 in 2022, then surged by 342.18% to $1.6 million in 2023, then plummeted by 78.93% to $333554.0 in 2024, then soared by 49.6% to $499000.0 in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $499000.0, $692000.0, and $441674.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.